Powered by

Thirteen-bagger PharmaCan Capital increases 1.7% on firm volume post EGM February 27, 2017 17:00 EST

Feb 27, 2017 - News Bites Canadian Markets


PharmaCan Capital Corp. (TSXV:MJN), Canada's 3rd largest Biotechnology company by market cap, rose for a second day on Monday bringing its two-day rise to 23.0c (8.2%). The stock price has increased 5.0c (1.7%) from its last trading session of February 24 to close at CAD3.05. Compared with the S&P/TSX 60 Index which fell 2.5 points (0.3%) in the day, the relative price increase was 1.9%. The rise has been propped up by firm volume of 1.3 times the average daily

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox